ECL Filing
4Filing Date: Jul 2, 2026

ECOLAB INC. (ECL) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001336007-26-000008open_in_new
Total Value$40.0K
Trades2
Insiders1

Transaction Details

Green Eric Mark
Director·Direct
Grant · Acquire
Common Stock
Shares+130.18
Price$0.00
Total Value$0
Shares Owned After4.11K
Transaction DateJun 30, 2026
Footnotes ▸

Includes 9.94 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.

Green Eric Mark
Director·Direct
Grant · Acquire
Common Stock
Shares+143.65
Price$278.46
Total Value$40.0K
Shares Owned After4.26K
Transaction DateJun 30, 2026

Post-Transaction Holdings

Green Eric Mark
SecuritySharesChange
Common Stock4.11K+273.83 (7.13%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-30 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ECOLAB INC. (ECL) CIK: 0000031462 --- Reporting Owner --- Name: Green Eric Mark CIK: 0001336007 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-30 | Code: A (Grant or award) Shares: +130.18 | Price: $0.00 Shares Owned After: 4,113.63 | Ownership: D (Direct) Footnotes: [F1] Includes 9.94 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. [Transaction #2] Security: Common Stock Date: 2026-06-30 | Code: A (Grant or award) Shares: +143.65 | Price: $278.46 Total Value: $40,000.49 Shares Owned After: 4,257.28 | Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: Includes 9.94 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. --- Signature --- /s/ /s/ Corinne Lawson, as Attorney-in-Fact for Eric M. Green (2026-07-02)

keid AI analysis is for reference only and does not constitute investment advice.